Editorial: Risk factors in multiple myeloma identified before and during treatment: are we ready to personalize treatment?

• Mattia D’Agostino,
• Carolina Terragna,
• Mark van Duin

Affiliations

Mattia D’Agostino

SSD Clinical Trial in Oncoematologia e Mieloma Multiplo, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy

Carolina Terragna

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy

Mark van Duin

Department of Haematology, Erasmus Medical Center, Rotterdam, Netherlands